2016 Apr 27
7 Signs of Ovarian Cancer You Might Be Ignoring
Kevin Holcomb, M.D., discusses some of the "silent" symptoms of ovarian cancer. Read more
2016 Apr 26
What the gut? Two studies explore microbiome-cancer connection
Teams at Weill Cornell Medicine are exploring the complex workings of the gastrointestinal microbiota and metabolome. Read more
2016 Apr 25
Cranberry compound packs powerful cancer punch
A compound made from cranberries has shown promise in killing several leukemia cell lines and blood samples from acute myelogenous leukemia (AML) patients. Read more
2016 Apr 25
Teenager helps ID new target for aggressive leukemia
Michael Albert, 17, has worked with the lab of Monica Guzman, Ph.D., to identify ephrin receptors as potential therapeutic targets for acute myeloid leukemia. Read more
2016 Apr 25
Drug developed for lymphoma could provide hope for lung cancer patients
The lab of Leandro Cerchietti, M.D., has revealed early evidence that a BCL6 inhibitor initially studied as a potential B-cell lymphoma treatment might also be effective against chemo-resistant non-small cell lung cancers. Read more
2016 Apr 21
Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC
Brendon Stiles, M.D., comments on the immunotherapies available to treat non-small cell lung cancer. Read more
2016 Apr 21
10 Things Cancer Experts Do To Avoid Getting The Disease
Allyson Ocean, M.D., shares some pointers with Prevention Magazine. Read more
2016 Apr 20
Copper depletion may reduce breast cancer relapse in patients at high risk
Linda Vahdat, M.D., shares results of studies into copper depletion as a potential therapy for triple-negative breast cancer. Read more
2016 Apr 19
Hollywood star honors star Meyer researchers
Weill Cornell Medicine researchers Juan Cubillos-Ruiz, Ph.D., and Dan Landau, M.D., Ph.D., were two of 10 young investigators nationwide who received Innovative Research Grants from Stand Up To Cancer. Read more
2016 Apr 19
Computer to clinic: Tool developed at Weill predicts drug success
A computational tool created by a graduate student in the lab of Olivier Elemento, Ph.D, has realized its first clinical application - less than a year after its development. Read more
2016 Apr 18
First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer
Scott Tagawa, M.D., M.S., discusses the results of a phase I/II trial into a promising new immunotherapy drug for bladder cancer. Read more
2016 Apr 17
Englander Institute joins international genomic medicine effort
Tumors sequenced at Weill Cornell Medicine/NewYork-Presbyterian could help further cancer research across the globe, as part of the International Cancer Genome Consortium Read more
2016 Apr 15
Panoply of new agents, complete remission rates mark ‘special day’ in myeloma
Ruben Niesvizky, M.D., discusses the “privilege” of caring for patients with myeloma in an era of therapeutic milestones. Read more
2016 Apr 15
The promise of combining radiotherapy and immunotherapy to treat cancer
Silvia Formenti, M.D., discusses her novel approach to immunotherapy using radiation treatment. Read more
2016 Apr 14
Cancer genomics: Hard-to-reach repairs
Ekta Khurana, Ph.D., comments on two studies about DNA repair mechanisms. Read more
2016 Apr 13
Lymphoma researchers earn Top 10 Clinical Research Award
The lymphoma clinical research group has received a Clinical Research Forum award for its study demonstrating the efficacy of an innovative combination therapy for treating mantle cell lymphoma. Read more
2016 Apr 13
Unraveling how obesity fuels cancer
Andrew Dannenberg, M.D., discusses the effect of inflammation and aromatase expression on breast cancer risk. Read more
2016 Apr 11
A Pathway to Success: Studying signal transduction in cancer and other diseases
Lewis Cantley, Ph.D., discusses his career in science Read more
2016 Apr 08
Scientists push to expand survival rates for brain cancer patients
One size does not fit all for brain cancer treatment, says Howard Fine, M.D. Read more
2016 Apr 08
The transformation of oncology
We are living in a remarkable time for cancer research - let's take advantage of it, says Harold Varmus, M.D., Read more
